FDA. Guidance For Industry. Investigator Responsibilities – Protecting The Rights, Safety, And Welfare Of Study Subjects.
I. INTRODUCTION
This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations. If you want to discuss an alternative approach, contact the FDA staff responsible for implementing this guidance. If you cannot identify the appropriate FDA staff, call the appropriate number listed on the title page of this guidance.
This guidance provides an overview of the responsibilities of a person who conducts a clinical investigation of a drug, biological product, or medical device (an investigator as defined in 21 CFR 312.3(b) and 21 CFR 812.3(i)). The goal of this guidance is to help investigators better meet their responsibilities with respect to protecting human subjects and ensuring the integrity of the data from clinical investigations. This guidance is intended to clarify for investigators and sponsors FDA’s expectations concerning the investigator’s responsibility (1) to supervise a clinical study in which some study tasks are delegated to employees or colleagues of the investigator or other third parties and (2) to protect the rights, safety, and welfare of study subjects.
FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.
Authors:
Center for Drug Evaluation and Research
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
OCTOBER 2009
Clinical Research News
即将进行的临床试验
-
Intuitive Surgical尚未招聘
-
University of Alabama at Birmingham尚未招聘Spinal Cord Disorders美国
-
Medical University of Vienna尚未招聘血管通路 | 血管通路并发症 | 透析导管感染 | 血液透析 | 血液透析并发症 | 透析通路功能障碍 | ESRD（终末期肾病） | 透析导管奥地利
-
NYU Langone HealthNational Cancer Institute (NCI)尚未招聘
-
M.D. Anderson Cancer Center尚未招聘
-
Prevention Strategies, LLCNational Institute on Drug Abuse (NIDA); NORC at the University of Chicago尚未招聘酒精相关疾病 | 烟草使用障碍 | 吸食大麻 | 物质相关疾病
-
Second Affiliated Hospital of Nanchang UniversityBeijing Pearl Biotechnology Limited Liability Company招聘中
-
Ming Liu尚未招聘
-
The First Affiliated Hospital of Soochow University尚未招聘
-
Peking University First HospitalPeking University Shenzhen Hospital尚未招聘老年患者 | 癌症手术 | 有针对性的温度管理 | 体温过低，意外 | 神经认知恢复延迟中国
Clinical Research Jobs
-
United Kingdom - London
-
Germany - Hessen
-
United States - North Carolina - Durham
-
Poland - Krakow
-
India - Bengaluru
-
United States - North Carolina - Morrisville
-
China
